Drugs / Micronized purified Flavonoid-Fraction
Micronized purified Flavonoid-Fraction
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04335617 | Feb 2020 → Feb 2023 | radiation proctitis | Medical University Innsbruck | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Micronized purified Flavonoid-Fraction | “MMPF (Micronized purified Flavonoid-Fraction)” NCT04335617 ↗ |
| Known as | MMPF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04335617 ↗ |
| Known as | MPFF | “Micronized Purified Flavonoid- Fraction (MPFF) in the Management of Radiation Proctitis” NCT04335617 ↗ |
| Route | Oral | “oral route” NCT04335617 ↗ |